All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated Loans

GSK and Pfizer agree market leading joint venture

Pills_230px

GlaxoSmithKline and Pfizer have agreed to combine their consumer health businesses to create a market leading joint venture with sales of around £9.8bn. The companies expect to divest assets to cover the cash cost of the integration.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree